Communicable Diseases and Health Programmes
Bacterial, viral, protozoan and vector-borne diseases, NCDs, sickle cell disease and India's elimination status (as of 2026) with health programmes, for CGPSC.
Prerequisites
- Cell and Human Body Systems — blood, lungs and liver, which these diseases attack.
- Nutrition and Deficiency Diseases — the non-infectious diseases and the infection–malnutrition cycle.
The Hook: A Fever in Bijapur
In the monsoon, a mitanin (मितानिन, Chhattisgarh’s community health worker) in a Bijapur village pricks the finger of a feverish child and puts a drop of blood on a small plastic strip. Two lines appear: malaria, Plasmodium falciparum. She starts treatment on the spot. The same week a town in central Chhattisgarh sees dengue cases after rain-water collects in coolers and old tyres. A TB patient two villages away gets a monthly nutrition payment through the Ni-kshay portal.
Three diseases, three kinds of germs, three different mosquitoes or routes. Why does malaria hit the forests while dengue hits towns? What has India eliminated, and what is still a target? This page answers these questions.
Why it matters: Prelims asks “disease–pathogen–vector” matches and “which disease has India eliminated?” statements. Mains GS-II asks about public health programmes, communicable vs non-communicable diseases and the health problems of tribal Chhattisgarh.
Pathogens (रोगजनक) and Routes of Spread
| Route | Examples |
|---|---|
| Air / droplets | Tuberculosis, influenza, measles, COVID-19, diphtheria, whooping cough, chickenpox |
| Contaminated food and water (faecal–oral) | Cholera, typhoid, hepatitis A and E, polio, amoebiasis, rotavirus diarrhoea |
| Vectors (रोगवाहक) | Malaria, dengue, chikungunya, filariasis, Japanese encephalitis, kala-azar, plague |
| Blood and body fluids | HIV/AIDS, hepatitis B and C |
| Direct contact | Leprosy (prolonged close contact), scabies, ringworm |
| Animal bite | Rabies (dogs in most Indian cases) |
Diseases by type of pathogen
| Bacterial | Viral | Protozoan | Fungal | Worms (helminths) |
|---|---|---|---|---|
| Tuberculosis (Mycobacterium tuberculosis, Koch, 1882) | Polio | Malaria (Plasmodium) | Ringworm | Filariasis (Wuchereria bancrofti) |
| Leprosy (Mycobacterium leprae, Hansen) | Measles, mumps, rubella | Kala-azar (Leishmania donovani) | Athlete’s foot | Roundworm (Ascaris) |
| Cholera (Vibrio cholerae) | AIDS (HIV) | Amoebic dysentery (Entamoeba histolytica) | Candidiasis | Hookworm (causes anaemia) |
| Typhoid (Salmonella typhi) | Hepatitis A–E | Sleeping sickness (Trypanosoma, tsetse fly; Africa) | Mucormycosis (“black fungus”) | Tapeworm (Taenia) |
| Tetanus (Clostridium tetani) | Rabies | Giardiasis | ||
| Diphtheria, whooping cough (pertussis) | Dengue, chikungunya, Zika | |||
| Plague (Yersinia pestis) | Influenza, COVID-19 (SARS-CoV-2) | |||
| Pneumonia (often bacterial; also viral) | Japanese encephalitis, chickenpox |
Vector-Borne Diseases (वाहक-जनित रोग)
| Vector | Disease(s) | Breeding / habit |
|---|---|---|
| Female Anopheles mosquito | Malaria | Clean water; bites mostly at night |
| Aedes aegypti (and Ae. albopictus) | Dengue, chikungunya, Zika, yellow fever | Clean stagnant water in coolers, tyres, pots; day-biter; typical of towns |
| Culex mosquito | Lymphatic filariasis, Japanese encephalitis | Dirty, polluted water. For JE, pigs are amplifying hosts and water birds the reservoir |
| Sandfly | Kala-azar (visceral leishmaniasis) | Cracks in mud walls, damp places |
| Rat flea | Plague | — |
| Tsetse fly | Sleeping sickness | Africa |
Malaria (मलेरिया) in detail
- Caused by the protozoan Plasmodium. The two main species in India are P. vivax and P. falciparum. P. falciparum causes the most severe form (cerebral malaria) and dominates in forested tribal belts such as Bastar and neighbouring Odisha.
- The parasite in human blood was first seen by Charles Laveran (1880). Ronald Ross showed in 1897 at Secunderabad that mosquitoes transmit it, and won the Nobel Prize in 1902.
- The parasite multiplies in the liver and then in red blood cells, which burst in cycles: hence the fever with chills, and anaemia.
- Diagnosis: blood smear or rapid diagnostic test (RDT). Treatment: chloroquine for vivax (with primaquine), artemisinin-based combination therapy (ACT) for falciparum. Artemisinin was discovered by Tu Youyou (Nobel Prize, 2015).
- National Framework for Malaria Elimination (2016–2030): zero indigenous cases by 2027 and elimination by 2030. India has left the WHO “High Burden to High Impact” group of countries.
Major Communicable Diseases: Key Facts
| Disease | Key facts |
|---|---|
| Tuberculosis (क्षय रोग) | Bacterial, airborne; mostly lungs. World TB Day: 24 March (Koch’s 1882 announcement). Programme: National TB Elimination Programme (NTEP); Pradhan Mantri TB Mukt Bharat Abhiyaan; national target to end TB by 2025, five years before the SDG 2030 target, which was not met. Ni-kshay is the online notification and patient-support portal. WHO Global TB Report 2025: India’s incidence fell about 21%, from 237 per lakh (2015) to 187 per lakh (2024), but India still carries about a quarter of the world’s TB cases |
| Leprosy (कुष्ठ रोग) | Bacterial; affects skin and nerves; curable with multi-drug therapy (MDT). India reached elimination as a public health problem (fewer than 1 case per 10,000 population) at the national level in 2005, but pockets of high prevalence remain. Anti-Leprosy Day: 30 January |
| HIV/AIDS | Virus attacks helper T cells (CD4), destroying immunity. Spread by unsafe sex, infected blood and needles, and mother to child. No cure, but lifelong antiretroviral therapy (ART) controls it. NACO (1992); HIV and AIDS (Prevention and Control) Act, 2017 bans discrimination |
| Hepatitis | A and E: water-borne, usually self-limiting. B, C, D: blood-borne; B and C can cause liver cirrhosis and cancer. Hepatitis B vaccine is part of the UIP; hepatitis C is curable with oral drugs. World Hepatitis Day: 28 July |
| Rabies | Viral; almost 100% fatal once symptoms start, but fully preventable with prompt wound washing and post-exposure vaccination (plus immunoglobulin for severe bites). Global goal: “Zero by 30” (no human deaths from dog-mediated rabies by 2030) |
| Dengue | Viral, four serotypes; Aedes; high fever, joint pain, falling platelet count; no specific antiviral, so fluids and monitoring |
| Cholera / typhoid | Water-borne bacteria; ORS saves lives in cholera; typhoid needs antibiotics; both are prevented by safe water and sanitation |
| COVID-19 | Virus SARS-CoV-2; WHO declared a pandemic on 11 March 2020. Its public health emergency of international concern was ended in May 2023 |
Elimination Status (as of 2026)
Eradication means zero cases worldwide permanently (only smallpox, declared in 1980, among human diseases). Elimination means interrupting transmission, or reducing cases below a set threshold, in a country or region.
timeline
title India's disease milestones
2000 : Guinea worm (dracunculiasis) - certified free
2005 : Leprosy - eliminated as a public health problem (national level)
2014 : Polio - WHO certifies the South-East Asia Region, including India, polio-free (27 March)
2015 : Maternal and neonatal tetanus - elimination validated
2016 : Yaws - India declared yaws-free (May)
2023 : Kala-azar - elimination threshold reached in all endemic blocks
2024 : Trachoma - WHO validates elimination as a public health problem (October)| Disease | Status (as of 2026) |
|---|---|
| Polio | Last wild poliovirus case: 13 January 2011 (Howrah, West Bengal). Certified 27 March 2014 with the WHO South-East Asia Region |
| Yaws | Declared free in May 2016; India was the first country declared yaws-free under WHO’s NTD roadmap |
| Maternal and neonatal tetanus | Elimination validated in 2015 (fewer than 1 case per 1,000 live births in every district) |
| Trachoma | WHO validated elimination as a public health problem in October 2024 |
| Kala-azar | India met the elimination threshold (fewer than 1 case per 10,000 people in every block) in 2023. It must be sustained for three years before WHO validation, which is pending. Endemic states: Bihar, Jharkhand, West Bengal, Uttar Pradesh |
| Lymphatic filariasis | Target: 2027 (three years ahead of the global 2030 goal) through annual mass drug administration (MDA); Chhattisgarh is among the endemic states |
| Malaria | Zero indigenous cases targeted by 2027, elimination by 2030 |
| Tuberculosis | National end-TB target of 2025 not met; work continues towards the SDG 2030 target |
| Measles and rubella | National Zero Measles-Rubella Elimination Campaign 2025–26, targeting elimination by 2026 |
| Sickle cell disease | Target: eliminate it as a public health problem by 2047 (see below) |
Sickle Cell Disease (सिकल सेल रोग): Chhattisgarh’s Genetic Challenge
- A genetic, non-communicable blood disorder caused by a mutation in the haemoglobin (beta-globin) gene. Red blood cells become sickle (crescent) shaped, stiff and short-lived, causing anaemia, pain crises, infections and organ damage.
- It is autosomal recessive: a person with one faulty gene is a carrier (sickle cell trait, usually healthy); a child who inherits the faulty gene from both carrier parents has the disease.
- The carrier state gives some protection against falciparum malaria, which is why the gene became common in historically malarial regions, including India’s central tribal belt.
- Chhattisgarh is among the states with the highest burden, along with Odisha, Madhya Pradesh, Maharashtra and Gujarat.
- Launched by the Prime Minister on 1 July 2023 at Shahdol, Madhya Pradesh.
- Aim: eliminate sickle cell disease as a public health problem by 2047.
- Strategy: screen 7 crore people aged 0–40 in tribal-dominated districts of 17 states by 2025–26, give each person a genetic status card, offer pre-marital and pre-conception counselling (so that two carriers know the risk to their children), and provide care such as hydroxyurea and folic acid.
- Progress: over 6 crore people had been screened by July 2025 (government data).
Thalassaemia is another inherited haemoglobin disorder; major forms need lifelong transfusions. A bone marrow (stem cell) transplant can cure both conditions, and gene therapies are emerging. See Biotechnology.
Non-Communicable Diseases (NCDs, गैर-संचारी रोग)
| Disease | Key point |
|---|---|
| Diabetes mellitus | Type 1: little or no insulin (often from childhood; autoimmune). Type 2: the body does not respond well to insulin (lifestyle-linked; most cases). India is often called a “diabetes capital” |
| Hypertension | BP persistently at or above about 140/90 mmHg; a “silent killer” leading to stroke, heart and kidney disease |
| Cardiovascular disease | Heart attack (blocked coronary artery), stroke |
| Cancers | Uncontrolled cell division (mitosis). Common in India: oral (tobacco), breast and cervical (HPV) |
| Chronic respiratory disease | COPD, asthma: smoking and indoor smoke from chulhas |
Risk factors: tobacco, alcohol, unhealthy diet (salt, sugar, trans-fat), physical inactivity, air pollution. NCDs now cause the majority of deaths in India.
Programme: the National Programme for Prevention and Control of Non-Communicable Diseases (NP-NCD), earlier NPCDCS (2010), runs population-based screening of people aged 30 and above for hypertension, diabetes and oral, breast and cervical cancers at Ayushman Arogya Mandirs.
India’s Health System and Programmes
| Programme | Year | Key point |
|---|---|---|
| National Health Mission (NHM) | NRHM 2005; NUHM and NHM 2013 | ASHA (in Chhattisgarh, the mitanin) community health workers, Janani Suraksha Yojana (2005), free drugs and diagnostics |
| Ayushman Bharat | 2018 | Two pillars: (1) Health and Wellness Centres, renamed Ayushman Arogya Mandir (2023), for comprehensive primary care; (2) PM-JAY |
| PM-JAY (Pradhan Mantri Jan Arogya Yojana) | Launched 23 September 2018, Ranchi | Cashless hospital cover of ₹5 lakh per family per year for secondary and tertiary care |
| Ayushman Vay Vandana card | 29 October 2024 | Extends PM-JAY cover to everyone aged 70 and above, regardless of income |
| Ayushman Bharat Digital Mission (ABDM) | 2021 | Digital health ID (ABHA) and health records |
| Pradhan Mantri Surakshit Matritva Abhiyan | 2016 | Free antenatal check-up on the 9th of every month |
Chhattisgarh:
- The Mitanin programme (मितानिन, “friend”) started in 2002, before NRHM, and was a model for the national ASHA scheme.
- Shaheed Veer Narayan Singh Ayushman Swasthya Yojana (the state’s name for its health-assurance scheme since June 2024) runs in convergence with PM-JAY: up to ₹5 lakh a year for Antyodaya and priority ration-card families and a smaller cover (₹50,000) for other families, as of 2026.
- Mukhyamantri Haat Bazaar Clinic Yojana (launched 2 October 2019) took mobile clinics to weekly tribal markets (haats), where remote villagers gather.
See Welfare and Development Programmes and Economy, Budget and State Schemes of Chhattisgarh for the wider scheme map.
Analysis for Mains: Health Challenges in Tribal Chhattisgarh
- Disease burden: falciparum malaria, sickle cell disease, TB, malnutrition and anaemia overlap in the same districts.
- Access: forests, scattered hamlets, poor roads and conflict in parts of the south make facilities hard to reach and staff hard to retain.
- Human resources: shortages of specialists at community health centres and district hospitals.
- Social factors: reliance on traditional healers, late care-seeking, low female literacy.
- What has worked: community health workers (mitanins), test-everyone campaigns (Malaria Mukt Bastar), outreach at weekly haats, sickle cell screening and genetic counselling.
Way forward: strengthen Ayushman Arogya Mandirs and telemedicine; incentives for doctors in remote postings; integrate malaria, TB, nutrition and sickle cell services; use local-language communication through mitanins and traditional leaders; better roads and connectivity.
Memory Tricks
Don’t Confuse
| This | vs | That |
|---|---|---|
| Eradication: zero worldwide (smallpox, 1980) | vs | Elimination: zero or below a threshold in one country or region |
| Kala-azar: protozoan, sandfly | vs | Filariasis: worm, Culex mosquito |
| Hepatitis A, E: water-borne | vs | Hepatitis B, C, D: blood-borne |
| Sickle cell trait: one gene, carrier, usually healthy | vs | Sickle cell disease: two genes, ill |
| Type 1 diabetes: no insulin | vs | Type 2 diabetes: insulin resistance, lifestyle |
| PM-JAY: hospital insurance, ₹5 lakh | vs | Ayushman Arogya Mandir: primary care centres |
| Charles Laveran: parasite in blood (1880) | vs | Ronald Ross: mosquito transmission (1897, Nobel 1902) |
Common Mistakes
- “India has been certified kala-azar-free by WHO.” False as of 2026. India reached the elimination threshold in 2023; WHO validation is pending until it is sustained for three years.
- “Dengue is spread by Anopheles.” False. It is spread by Aedes, a day-biting mosquito.
- “Leprosy has been eradicated from India.” False. India eliminated it as a public health problem (below 1 per 10,000) in 2005; new cases still occur.
- “Sickle cell disease is caused by iron deficiency.” False. It is genetic (a haemoglobin gene mutation).
- “Antibiotics cure viral infections.” False. They act only on bacteria.
- “India met its 2025 target to end TB.” False. Incidence fell but the target was not met.
Practice
All questions below are original practice questions written in CGPSC style. They are not previous-year questions.
Level 1: Foundation
- Kala-azar is transmitted by the ______.
- The causative agent of tuberculosis is ______.
- Chhattisgarh’s community health workers, the model for ASHAs, are called ______.
Answers
- Sandfly.
- Mycobacterium tuberculosis (a bacterium).
- Mitanins.
Level 2: Prelims MCQs
Q1. Consider the following statements about India’s disease-control status (as of 2026):
- India was declared yaws-free in 2016.
- WHO has validated India’s elimination of kala-azar as a public health problem.
- WHO validated India’s elimination of trachoma as a public health problem in 2024.
Which of the statements given above is/are correct?
- (a) 1 only
- (b) 1 and 3 only
- (c) 2 and 3 only
- (d) 1, 2 and 3
Answer and explanation
Q2. Match List I (Disease) with List II (Vector):
| List I | List II |
|---|---|
| A. Malaria | 1. Culex mosquito |
| B. Dengue | 2. Sandfly |
| C. Lymphatic filariasis | 3. Aedes mosquito |
| D. Kala-azar | 4. Female Anopheles mosquito |
- (a) A-4, B-1, C-3, D-2
- (b) A-4, B-3, C-1, D-2
- (c) A-3, B-4, C-1, D-2
- (d) A-4, B-3, C-2, D-1
Answer and explanation
Q3. Which of the following diseases is caused by a protozoan?
- (a) Typhoid
- (b) Amoebic dysentery
- (c) Hepatitis A
- (d) Ringworm
Answer and explanation
Q4. With reference to the National Sickle Cell Anaemia Elimination Mission, which of the following is correct?
- (a) It was launched in 2023 and aims to eliminate the disease as a public health problem by 2047.
- (b) It was launched in 2019 and aims at elimination by 2030.
- (c) It covers only Chhattisgarh and Odisha.
- (d) It relies mainly on mass drug administration.
Answer and explanation
Q5. The “Malaria Mukt Bastar Abhiyan” was distinctive because it:
- (a) distributed a malaria vaccine to all children
- (b) tested everyone in target villages, including people without fever
- (c) relied only on spraying DDT
- (d) was run entirely by private hospitals
Answer and explanation
Level 3: Mains Answer Writing
Q1. (60 words) Distinguish between disease elimination and eradication with Indian examples.
Model answer outline
- Eradication: permanent reduction to zero cases worldwide; no further control needed. Example: smallpox (declared 1980).
- Elimination: zero transmission, or cases below a threshold, in a defined area, with continued control. Examples: polio (India certified 2014), yaws (2016), trachoma as a public health problem (2024); kala-azar threshold reached in 2023 with validation pending.
Q2. (150–200 words) “Tribal Chhattisgarh faces a triple burden of malaria, sickle cell disease and malnutrition.” Discuss, with the measures taken.
Model answer outline
- Intro: The forested southern and northern districts combine falciparum malaria, a high sickle cell gene frequency and high stunting and anaemia (NFHS-5).
- How they interact: malaria destroys RBCs and worsens anaemia; sickle cell disease causes chronic anaemia and infections; malnutrition lowers immunity, so each makes the others worse.
- Measures:
- Malaria Mukt Bastar Abhiyan (2020): test-everyone campaigns; state-reported positivity fell from 4.60% to 0.51% (2020–23).
- National Sickle Cell Anaemia Elimination Mission (2023): screening ages 0–40, genetic cards, counselling, hydroxyurea.
- Nutrition: Poshan 2.0, Mukhyamantri Suposhan Abhiyan (2019), fortified rice, Anaemia Mukt Bharat.
- Delivery: mitanins, haat-bazaar clinics, Ayushman Arogya Mandirs.
- Gaps: staff shortages, access in conflict areas, follow-up after screening.
- Conclusion: An integrated tribal health package that combines screening, nutrition and vector control, delivered through community workers, is the way forward.
Quick Revision Table
| Fact | Detail |
|---|---|
| Malaria | Plasmodium (protozoan); female Anopheles; Ross 1897, Nobel 1902 |
| Dengue, chikungunya, Zika | Viruses; Aedes, day-biter, clean water |
| Filariasis, JE | Culex; filariasis elimination target 2027 |
| Kala-azar | Leishmania donovani; sandfly; threshold met 2023, WHO validation pending |
| TB | Koch 1882; World TB Day 24 March; incidence 237 → 187 per lakh (2015–2024) |
| Leprosy | Hansen; MDT; national elimination as a public health problem 2005 |
| Polio | Last case 13 Jan 2011; certified 27 March 2014 |
| Yaws / MNT / Trachoma | 2016 / 2015 / October 2024 |
| Smallpox | Only eradicated human disease (1980) |
| Malaria targets | Zero indigenous cases 2027; elimination 2030 |
| Measles-rubella | Elimination target 2026 |
| Sickle cell mission | 1 July 2023, Shahdol; 7 crore screening (0–40 yrs), 17 states; target 2047 |
| PM-JAY | 23 Sept 2018; ₹5 lakh per family per year |
| Vay Vandana | 29 Oct 2024; all aged 70+ |
| Mitanin | Chhattisgarh, 2002; model for ASHA |
| Malaria Mukt Bastar | January 2020; test everyone |
Key Takeaways
- Learn every disease as pathogen type → organism → route or vector → programme.
- Separate eradication (smallpox only) from elimination (polio, yaws, MNT, trachoma) and from targets (kala-azar validation, filariasis 2027, malaria 2030, measles-rubella 2026, sickle cell 2047).
- Time-sensitive facts carry dates: WHO TB Report 2025 data, the 2023 kala-azar threshold, the 2024 trachoma validation.
- Sickle cell disease is genetic and recessive; Chhattisgarh is a high-burden state under the 2023 national mission.
- NCDs now cause most deaths; screening at Ayushman Arogya Mandirs and PM-JAY insurance are the twin responses.
What’s Next
- Vaccines and Immunity — how the body fights these pathogens and how vaccines help
- Biotechnology — diagnostics, gene therapy and vaccine technology
- Tribes of Chhattisgarh — the communities most affected by the diseases above
- Environmental Pollution and Waste Management — water, sanitation and disease